January 29, 2018 / 12:20 PM / 3 months ago

BRIEF-Alder Biopharmaceuticals Announces Offering Of $200 Mln Convertible Senior Notes

Jan 29 (Reuters) - Alder Biopharmaceuticals Inc:

* ALDER BIOPHARMACEUTICALS, INC. ANNOUNCES OFFERING OF $200 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2025

* ALDER BIOPHARMACEUTICALS - INTENDS TO USE PROCEEDS FROM OFFERING TO FUND DEVELOPMENT, COMMERCIALIZATION OF EPTINEZUMAB Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below